Minimally invasive operation for breast cancer

Current Problems in Surgery

Volumn 41, Issue 4, 2004, Pages 394-447

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; SULFUR 35; TAMOXIFEN; TECHNETIUM 99M; TRACER;

ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; BREAST DUCT; CATHETER ABLATION; COLLOID; CRYOSURGERY; CYTOLOGY; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; LASER SURGERY; LAVAGE; LYMPHOSCINTIGRAPHY; MEDICAL DECISION MAKING; MINIMALLY INVASIVE SURGERY; PARTIAL MASTECTOMY; REVIEW; RISK BENEFIT ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 1942471070     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpsurg.2003.12.002     Document Type: Article

References (153)

1. Okazaki A. Okazaki M. Asaishi K. Satoh H. Watanabe Y. Mikami T. et al. Fiberoptic ductoscopy of the breast: a new diagnostic procedure for nipple discharge Jpn J Clin Oncol 21 1991 188-193
2. Okazaki A. Okazaki M. Hirata K. Tsumanuma T. Progress of ductoscopy of the breast Nippon Geka Gakkai Zasshi 97 1996 357-362
3. Okazaki A. Hirata K. Okazaki M. Svane G, Azabedo E. Nipple discharge disorders: current diagnostic management and the role of fiberductoscoy Eur Radiol 9 1999 583-590
4. Shen K.W. Wu J. Lu J.S. Han Q.Z. Shen Z.Z. Nguyen M. Shao Z.M. Barsky S.H. Fiberoptic ductoscopy for patients with nipple discharge Cancer 89 2000 1512-1519
5. Shao Z.M. Liu Y. Nguyen M. The role of the breast ductal system in the diagnosis of cancer Oncol Rep 8 2001 153-156
6. Matsunaga T. Ohta D. Misaka T. Hosokawa K. Fujii M. Kaise H. et al. Mammary ductoscopy for diagnosis and treatment of intraductal lesions of the breast Breast Cancer 8 2001 213-221
7. Shen K.W. Wu J. Lu J.S. Han Q.X. Shen Z.Z. Nguyen M. et al. Fiberoptic ductoscopy for breast cancer patients with nipple discharge Surg Endosc 15 2001 1340-1345
8. Yamamoto D. Shoji T. Kawanishi H. Nakagawa H. Haijima H. Gondo H. et al. A utility of ductography and fiberoptic ductoscopy for patients with nipple discharge Breast Cancer Res Treat 70 2001 103-108
9. Yamamoto D. Ueda S. Senzaki H. Shoji T. Haijima H. Gondo H. et al. New diagnostic approach to intracystic lesions of the breast by fiberoptic ductoscopy Anticancer Res 21 2001 4113-4116
10. Makita M. Akiyama F. Gomi N. Ikenaga M. Yoshimoto M. Kasumi F. et al. Endoscopic classification of intraductal lesions and histological diagnosis Breast Cancer 9 2002 220-225
11. Tamaki Y. Miyoshi Y. Noguchi S. Application of endoscopic surgery for breast cancer treatment Nippon Geka Gakkai Zasshi 103 2002 835-838
12. Love S.M. Barsky S. Breast-duct endoscopy to study stages of cancerous breast disease Lancet 348 1996 997-999
13. Dooley W.C. Ljung B.-M. Veronesi U. Cazzaniga M. Elledge R.M. O'Shaughnessy J.A. et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer J Natl Can Inst 93 2001 1624-1632
14. Khan S.A. Baird C. Staradub V.L. Morrow M. Ductal lavage and ductoscopy: the opportunities and the limitations Clin Breast Cancer 3 2002 185-191
15. Dietz J.R. Crowe J.P. Grundfest S. Arrigain S. Kim J.A. Directed duct excision by using mammary ductoscopy in patients with pathologic nipple discharge Surgery 132 2002 582-587
16. Dooley W.C. Routine operative breast endoscopy during lumpectomy Ann Surg Oncol 10 2003 38-42
17. Dooley W.C. Routine operative breast endoscopy for bloody nipple discharge Ann Surg Oncol 9 2002 920-923
18. Dooley W.C. Ductal lavage, nipple aspiration, and ductoscopy for breast cancer diagnosis Curr Oncol Rep 5 2003 63-65
19. Hutchinson W.B. Thomas D.B. Hamlin W.B. Roth G.J. Peterson A.V. Williams B. Risk of breast cancer in women with benign breast disease J Natl Cancer Inst 65 1980 13-20
20. Dupont W.D. Page D.L. Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 312 1985 146-151
21. Wrensch M.R. Petrakis N.L. King E.B. Miike R. Mason L. Chew K.L. et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid Am J Epidemiol 135 1992 130-141
22. Page D.L. Dupont W.D. Anatomic indicators (histologic and cytologic) of increased breast cancer risk Breast Cancer Res Treat 28 1993 157-166
23. Carter C.L. Corle D.K. Micozzi M.S. Schatzkin A. Taylor P.R. A prospective study of the development of breast cancer in 16,692 women with benign breast disease Am J Epidemiol 128 1988 467-477
24. Palli D. Rosselli del Turco M. Simoncini R. Bianchi S. Benign breast disease and breast cancer: a case-control study in a cohort in Italy Int J Cancer 47 1991 703-706
25. Krieger N. Hiatt R.A. Risk of breast cancer after benign breast diseases: variation by histologic type, degree of atypia, age at biopsy, and length of follow-up Am J Epidemiol 135 1992 619-631
26. London S.J. Connolly J.L. Schnitt S.J. Colditz G.A. A prospective study of benign breast disease and the risk of breast cancer JAMA 267 1992 941-944
27. McDivitt R.W. Stevens J.A. Lee N.C. Wingo P.A. Rubin G.L. Gersell D. Histologic types of benign breast disease and the risk for breast cancer: the Cancer and Steroid Hormone Study Group Cancer 69 1992 1408-1414
28. Bodian C.A. Perzin K.H. Lattes R. Hoffmann P. Abernathy T.G. Prognostic significance of benign proliferative breast disease Cancer 71 1993 07-3896
29. Dupont W.D. Parl F.F. Hartmann W.H. Brinton L.A. Winfield A.C. Worrell J.A. et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia Cancer 71 1993 1258-1265
30. Dupont W.D. Page D.L. Parl F.F. Plummer W.D. Jr Schuyler P.A. Kasami M. et al. Estrogen replacement therapy in women with a history of proliferative breast disease Cancer 85 1999 1277-1283
31. Byrne C. Connolly J.L. Colditz G.A. Schnitt S.J. Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk Cancer 89 2000 2046-2052
32. Fabian C.J. Kimler B.F. Zalles C.M. Klemp J.R. Kamel S. Zeiger S. et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model J Natl Cancer Inst 92 2000 1217-1227
33. Wrensch M.R. Petrakis N.L. Miike R. King E.B. Chew K. Neuhaus J. et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid J Natl Cancer Inst 93 2001 1791-1798
34. Port E.R. Montgomery L.L. Heerdt A.S. Borgen P.I. Patient reluctance toward tamoxifen use for breast cancer primary prevention Ann Surg Oncol 8 2001 580-585
35. Vogel V.G. Costantino J.P. Wickerham D.L. Cronin W.M. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 94 2002 1504
36. Rossouw J.E. Anderson G.L. Prentice R.L. LaCroix A.Z. Kooperberg C. Stefanick M.L. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321-333
37. Clemons M. Loijens L. Goss P. Breast cancer risk following irradiation for Hodgkin's disease Cancer Treat Rev 26 2000 291-302
38. Morrow M. Vogel V. Ljung B.M. O'Shaughnessy J.A. Evaluation and management of the woman with an abnormal ductal lavage J Am Coll Surg 194 2002 648-656
39. Mitchell G. Trott P.A. Morris L. Coleman N. Sauter E. Eeles R.A. Cellular characteristics of nipple aspiration fluid during the menstrual cycle in healthy premenopausal women Cytopathology 12 2001 184-196
40. Kuerer H.M. Thompson P.A. Krishnamurthy S. Fritsche H.A. Marcy S.M. Babiera G.V. et al. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer Clin Cancer Res 9 2003 601-605
41. Liu Y. Wang J.L. Chang H. Barsky S.H. Nguyen M. Breast-cancer diagnosis with nipple fluid bFGF Lancet 356 2000 567
42. Zhao Y. Verselis S.J. Klar N. Sadowsky N.L. Kaelin C.M. Smith B. et al. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts J Clin Oncol 19 2001 1462-1467
43. Evron E. Dooley W.C. Umbricht C.B. Rosenthal D. Sacchi N. Gabrielson E. et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR Lancet 357 2001 1335-1336
44. Weber B.L. Cancer genomics Cancer Cell 1 2002 37-47
45. Krishnamurthy S. Sneige N. Ordonez N.G. Hunt K.K. Kuerer H.M. Characterization of foam cells in nipple aspirate fluid Diagn Cytopathol 27 2002 261-264
46. King B.L. Crisi G.M. Tsai S.C. Haffty B.G. Phillips R.F. Rimm D.L. Immunocytochemical analysis of breast cells obtained by ductal lavage Cancer 96 2002 244-249
47. Krag D. Weaver D. Alex J. Fairbank J. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe Surg Oncol 2 1993 335-340
48. Giuliano A. Kirgan D. Guenther J. Morton D. Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 1994 391-401
49. Albertini J. Lyman G. Cox C. Yeatman T. Balducci L. Ku N. et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer JAMA 276 1996 1818-1822
50. Morton D. Wen D. Wong J. Economou J. Cagle L. Storm F. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392-399
51. Kern K. Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of technetium 99m sulfur colloid J Am Coll Surg 193 2001 601-608
52. Kern K. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye J Am Coll Surg 189 1999 539-545
53. Kern K. Rosenberg R. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99-m sulfur colloid J Am Coll Surg 191 2000 479-489
54. Kern K. Sentinel lymph node mapping - reply J Am Coll Surg 190 2000 502-503
55. Kern K. Breast lymphatic mapping: reply J Am Coll Surg 4 2001 462-465
56. Rouviere H. Anatomie des Lymphatics de L'Homme. Tobias M, translator. Ann Arbor, Michigan: Edwards Bros Inc; 1938
57. Grant R. Tabah J. Adair F. The surgical significance of the subareolar lymph plexus in cancer of the breast Surgery 33 1953 71-78
58. Turner-Warwick R. The lymphatics of the breast Br J Surg 46 1959 574-582
59. Kern K. Lymphoscintigraphic anatomy of sentinel lymphatic channels: reply J Am Coll Surg 194 2002 846-847
60. Tuttle T. Zogakis T. Dunst C. Zera R. Singletary S. A review of technical aspects of sentinel lymph node identification for breast cancer J Am Coll Surg 195 2002 261-268
61. Hsueh E. Hansen N. Giuliano A. Intraoperative lymphatic mapping and sentinel node dissection in breast cancer CA Cancer J Clin 50 2000 279-291
62. Kern K. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid J Am Coll Surg 195 2002 467-475
63. Krag D. Weaver D. Ashikaga T. Moffat F. Klimberg V.S. Shriver C. et al. The sentinel node in breast cancer: a multicenter validation study N Engl J Med 339 1998 941-946
64. McMasters K. Wong S. Martin R. et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study Ann Surg 233 2001 676-687
65. Cox C. Salud C. Nguyen K. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67 2001 513-519
66. Albo D. Ames F. Hunt K. Ross M. Singletary S. Kuerer H. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy Breast Cancer Res Treat 77 2003 9-14
67. Balch G. Mithani S. Richards K. Beauchamp R.D. Kelley M.C. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer Ann Surg Oncol 10 2003 616-621
68. Feldman S. Krag D. McNally R. Moor B.B. Weaver D.L. Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy J Am Coll Surg 188 1999 248-254
69. Kumar R. Jana S. Heiba S. Dakhel M. Axelrod D. Siegel B. et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer J Nucl Med 44 2003 7-10
70. Lucci A. Kelemen P. Miller C. Chardkoff L. Wilson L. National practice patterns of sentinel lymph node dissection for breast carcinoma J Am Coll Surg 192 2000 453-458
71. Mariani G. Moresco L. Viale G. Villa G. Bagnasco M. Canavese G. et al. Radioguided sentinel lymph node biopsy in breast cancer surgery J Nucl Med 42 2001 1198-1215
72. Kern K. Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique J Am Coll Surg 192 2001 545-550
73. Klimberg V.S. Rubio I.T. Henry R. Cowan C. Colvert M. Korourian S. Subareolar versus peritumoral injection for location of the sentinel lymph node Ann Surg 229 1999 860-864
74. Cody H. Fey J. Akhurst T. Fazzari M. Mazumdar M. Yeung H. et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures Ann Surg Oncol 8 2001 13-19
75. Tuttle T. Colbert M. Christense R. Ose K. Jones T. Wetherille R. et al. Subareolar injection of 99mTc facilitates sentinel lymph node identification Ann Surg Oncol 9 2002 77-81
76. Mertz L. Mathelin C. Marin C. Cairard B. Chenard M.P. Brettes J.P. et al. Subareolar injection of 99m-Tc sulfur colloid for sentinel node identification in multifocal invasive breast cancer Bull Cancer 86 1999 939-945
77. Roumen R. Geuskens L. Valkenburg J. In search of the true sentinel node by different injection techniques in breast cancer patients Eur J Surg Oncol 25 1999 347-351
78. Borgstein P. Meijer S. Pijpers R. van Diest P. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method Ann Surg 232 2000 81-89
79. Mignotte H. Treilleux I. Chassagne-Clement C. Ben C. Lopez R. Martin X. et al. Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer Bull Cancer 87 2000 600-603
80. Donahue E. Sentinel node imaging and biopsy in breast cancer patients Am J Surg 182 2001 426-428
81. Smith L. Cross M. Klimberg V. Subareolar injection is a better technique for sentinel lymph node biopsy Am J Surg 180 2001 434-438
82. Simmons R. Thevarajah S. Brennan M. Christos P. Osborne M. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization Ann Surg Oncol 10 2003 242-247
83. Kern K. A rational approach to internal mammary node biopsy in the era of lymphatic mapping for breast cancer J Surg Oncol 79 2002 5-9
84. Fisher B. Bryant J. Wolmark N. Mamounas E. Brown A. Fisher E.R. et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 1998 2672-2685
85. Fisher B. Brown A. Mamounas E. Wieand S. Robidoux A. Margolese R.G. et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 1997 2483-2493
86. Kuerer H.M. Newman L.A. Smith T.L. Ames F.C. Hunt K.K. Dhingra K. et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol 17 1999 460-469
87. Kuerer H.M. Newman L.A. Buzdar A.U. Dhingra K. Hunt K.K. Buchholz T.A. et al. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status Cancer J Sci Am 4 1998 230-236
88. Singletary S.E. New approaches to surgery for breast cancer Endocr Relat Cancer 8 2001 265-286
89. Early Breast Cancer Trialists' Collaborative Group Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials N Engl J Med 333 1995 1444-1455
90. Pierce S.M. Recht A. Lingos T.I. Abner A. Vicini F. Silver B. et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer Int J Radiat Oncol Biol Phys 23 1992 915-923
91. Schlembach P.J. Buchholz T.A. Ross M.I. Kirsner S.M. Salas G.J. Strom E.A. et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation Int J Radiat Oncol Biol Phys 51 2001 671-678
92. Sable M, Schott AF, Kleer CG, Merajver S, Cimmino VM, Diehl KM, et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg (In Press)
93. Breslin T.M. Cohen L. Sahin A. Fleming J.B. Kuerer H.M. Newman L.A. et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer J Clin Oncol 18 2000 3480-3486
94. Kuerer H.M. Sahin A.A. Hunt K.K. Newman L.A. Breslin T.M. Ames F.C. et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy Ann Surg 230 1999 72-78
95. Dookeran K.A. Zaren H.A. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy Proc Am Soc Clin Oncol 18 1999 72A
96. Nason K.S. Anderson B.O. Byrd D.R. Dunnwald L.K. Eary J.F. Mankoff D.A. et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma Cancer 89 2000 2187-2194
97. Fernandez A. Cortes M. Benito E. Azpeitia D. Prieto L. Moreno A. et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme Nucl Med Commun 22 2001 361-366
98. Mamounas E, Brown A, Smith R, Julian T, Miller, B, Anderson S, et al. Sentinel node biopsy following neoadjuvant chemotherapy in breast cancer: results from NSABP B-27. Proceedings of the 54th Annual Meeting of the Society of Surgical Oncology, Washington, D.C., March 15-18, 2001:S51
99. Haid A. Tausch C. Lang A. Lutz J. Fritzsche H. Peschina W. et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 92 2001 1080-1084
100. Julian T.B. Patel N. Dusi D. Olson P. Nathan G. Jasnosz K. et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer Am J Surg 182 2001 407-410
101. Tafra L. Verbanac K.M. Lannin D.R. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer Am J Surg 182 2001 312-315
102. Montgomery LL, Van Zee KJ, Fey JV, Heerdt AS, Gemignani ML, Port ER, et al. Sentinel lymph node accuracy following neoadjuvant chemotherapy in breast cancer. Proceedings of the 55th Annual Meeting of the Society of Surgical Oncology, Washington, D.C., March 14-17, 2002:S49
103. Piato J.R. Barros A.C. Pincerato K.M. Sampaio A.P. Pinotti J.A. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy: a pilot study Eur J Surg ncol 29 2002 118-120
104. Stearns V. Ewing C.A. Slack R. Penannen M.F. Hayes D.F. Tsangaris T.N. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer Ann Surg Oncol 9 2002 235-242
105. Miller A.R. Thomason V.E. Yeh I.T. Alrahwan A. Sharkey F.E. Stauffer J. et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma Ann Surg Oncol 9 2002 243-247
106. Brady E.W. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer Breast J 8 2002 97-100
107. Balch G.C. Mithani S.K. Richards K. Beauchamp R.D. Kelley M.C. Prospective evaluation of accuracy of lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for locally advanced breast cancer Ann Surg Oncol 10 2003 616-621
108. Meyer J.E. Smith D.N. Lester S.C. Kaelin C. DiPiro P.J. Denison C.M. et al. Large-core needle biopsy of nonpalpable breast lesions JAMA 281 1999 1638-1641
109. Fine R. Boyd B.A. Whitworth P.W. Kim J.A. Harness J.K. Burak W.E. Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance Am J Surg 184 2002 332-336
110. Burbank F. Parker S.H. Fogarty T.J. Stereotactic breast biopsy: improved tissue harvesting with the Mammotome Am Surg 62 1996 738-744
111. Fine R. Whitworth P.W. Kim J.A. Harness J.K. Boyd B.A. Burak W.E. Low risk palpable breast masses removed using a vacuum-assisted hand-held device: 6-month follow-up Am J Surg 186 2003 362-367
112. Tafra L, Smith SJ, Woodward JE, Fernandez KL, Sawyer KT, Grenko RT. Pilot trial of cryo-assisted breast conserving surgery for small ultrasound visible breast cancers. Ann Surg Oncol 2003;10:1018-24
113. Burak WE Jr, Povoski SP, Yanssens TL, Sinclair DS, Bloom KJ, Wakely PE, et al. Radiofrequency ablation of invasive breast cancer followed by delayed surgical excision. San Antonio, Texas: Proceedings of the 25th San Antonio Breast Cancer Symposium; December 2003. 2003:451
114. Orel S.G. Schnall M.D. LiVolsi V.A. Troupin R.H. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation Radiology 190 1994 485-493
115. Boetes C. Mus R.D. Holland R. Barentsz J.O. Strijk S.P. Wobbest T. et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent Radiology 197 1995 743-747
116. Douek M. Maidya J.S. Lakhani S.R. Hall-Craggs M. Baum M. Taylor I. Can MRI be used to elucidate the natural history of breast cancer multicentricity? Lancet 351 1998 801-802
117. Orel S.G. Mendonca M.H. Reynolds C. Schnall M.D. Solin L.J. Sullivan D.C. MR imaging of ductal carcinoma in situ Radiology 202 1997 413-420
118. Weinstein S.P. Orel S.G. Heller R. Reynolds C. Czerniecki B. Soli L.J. et al. MR imaging of the breast in patients with invasive lobular carcinoma Am J Roentgenol 176 2001 399-406
119. Zlotta A.R. Wildschutz T. Raviv G. Penv M.O. van Gansbeke D. Noel J.C. et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience J Endourol 11 1997 251-258
120. Jeffrey S.S. Birdwell R.I. Ikeda D.M. Daniel B.L. Nowels K.W. Dirbas F.M. et al. Radiofrequency ablation of breast cancer Arch Surg 134 1999 1064-1069
121. Izzo F. Thomas R. Delrio P. Rinaldo M. Vallone P. DeChiara A. et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients Cancer 92 2001 2036-2044
122. Mirza AN, Fornage BD, Sneige N, Simmons R, Giuliano A, Hansen N, et al. Radiofrequency ablation of early-stage invasive breast tumors: results of a multi-center study. San Antonio, Texas: Proceedings of the 25th San Antonio Breast Cancer Symposium; December 2003. 2003:450
123. Hayashi A.H. Silver S.F. van der Westhuizen N.G. Donald J.C. Parker C. Frazer S. et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation Am J Surg 185 2003 429-435
124. Drezak R, Lin A, Chen J, Loo C, West J, Halas N. Optical technologies for noninvasive functional and molecular imaging. In: Singletary SE, Hortobagyi G, Robb G, eds. Advanced Therapy of Breast Disease, 2nd ed. Hamilton, Ontario, Canada: BC Decker Inc; (In press) Ch. 87
125. Breslin TM, Xu F, Palmer GM, Zhu C, Gilchrist KW, Ramanujam NR. Autofluorescence and diffuse reflectance properties of malignant and benign breast tissues. Ann Surg Oncol 2004;11:65-70
126. Heywang-Kobrunner S.H. Weiwad W. Lampe D. Buchmann J. Preservation of histopathologic assessment by use of a special technique for tissue inactivation by radiofrequency Breast Cancer Res Treat 71 2002 8588
127. Dupuy D.E. Safran H. Mayo-Smith W.W. Goldberg S.N. Radiofrequency ablation of painful osseous metastases Radiology 209 1998 389
128. Wood BJ, Fojo A, Levy EB, Gomez-Jorge J, Chang R, Spies J. Radiofrequency ablation of painful neoplasms as a palliative therapy: early experience. J Vasc Interv Radiol 20000;11S:207
129. Fujimoto S. Kobayashi K. Takahashi M. Nemoto K. Yamamoto I. Mutou T. et al. Clinical pilot studies on pre-operative hyperthermic tumor ablation for advanced breast carcinoma using an 8 mHz radiofrequency heating devise Int J Hyperthermia 19 2003 13-22
130. Fleischer D. Sivak M.V. Palliative Nd: YAG laser therapy as palliative treatment for advanced adenocarcinoma of the gastric cardia Gastroenterology 87 1984 815-820
131. Hetzel M.R. Nixon C. Edmondstone W.M. Laser therapy in 100 tracheobronchial tumors Thorax 40 1985 341-345
132. Bown S.G. Barr H. Metthewson K. Endoscopic treatment of inoperable colorectal cancers with the Nd: YAG laser Br J Surg 73 1986 949-952
133. Swain C.P. Bown S.G. Edwards D.A.W. Kirkham J.S. Salmon P.R. Clark C.G. Laser recanalization of obstructing foregut cancer Br J Surg 71 1984 112-115
134. Bown S.G. Phototherapy of tumors World J Surg 7 1983 700-709
135. Harries S.A. Amin Z. Smith E.F. Lees W.R. Cooke J. Cook M.G. et al. Interstitial laser photocoagulation as a treatment for breast cancer Br J Surg 81 1994 1617-1619
136. Mumtaz H. Hall-Craggs M.A. Wotherspoon A. Paley M. Buonaccorsi G. Amin Z. et al. Laser therapy for breast cancer: MR imaging and histopathologic correlation Radiology 200 1996 651-658
137. Milne P.J. Parel J.M. Manns F. Denham D.B. Gonzalez-Cirre X. Robinson D.S. Development of stereotactically guided laser interstitial thermotherapy of breast cancer: in situ measurement and analysis of the temperature field in ex vivo and in vivo adipose tissue Laser Surg Med 26 2000 67-75
138. Dowlatshahi K. Fan M. Shekarloo M. Bloom K. Gould V. Stereotactic interstitial laser therapy of early-stage breast cancer Breast J 2 1996 304-311
139. Dowlatshahi K. Fan M. Gould V. Bloom K.J. Ali A. Stereotactically guided laser therapy of occult breast tumors-work in progress report Arch Surg 135 2000 1345-1352
140. Dowlatshahi K. Francescatti D.S. Bloom K.J. Laser therapy for small breast cancers Am J Surg 184 2002 359-363
141. Dowlatshahi K, Fan M. Interstitial laser therapy (ILT) with diode laser: correlation of laser energy and tumor coagulation. Laser Surg Med 1995;Suppl 7:20
142. Toth B.A. Lappert T. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning Plast Reconstr Surg 87 1991 1048-1053
143. Carlson G.W. Bostwick J. 3rd Styblo T.M. Moore B. Bried J.T. Murray D.J. et al. Skin-sparing mastectomy: oncologic and reconstructive considerations Ann Surg 225 1997 570-575
144. Slavin S.A. Schnitt S.J. Duda R.B. Houlihan M.J. Koufman C.N. Morris D.J. et al. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer Plast Reconstr Surg 102 1998 49-62
145. Newman L.A. Kuerer H.M. Hunt K.K. Kroll S.S. Ames F.C. Ross M.I. et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction Ann Surg Oncol 5 1998 620-626
146. Simmons R.M. Fish S.K. Gayle L. La Trenta G.S. Swistel A. Christos P. et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies Ann Surg Oncol 6 1999 676-681
147. Kroll S.S. Khoo A. Singletary S.E. Ames F.C. Wang B.G. Reece G.P. et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up Plast Reconstr Surg 104 1999 421-425
148. Laronga C, Kemp B, Johnston D, Robb GL, Singletary SE. The incidence of occult nipple-areola complex involvement in breast cancer patients receiving skin-sparing mastectomy. Ann Surg Oncol 12999:6:609-13
149. Foster R.D. Esserman L.J. Anthony J.P. Hwang E.S. Do H. Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma Ann Surg Oncol 9 2002 462-466
150. Medina-Franco H. Vasconez L.O. Fix R.J. Heslin M.J. Beenken S.W. Bland K.I. et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer Ann Surg 235 2002 814-819
151. Carlson G.W. Styblo T.M. Lyles R.H. Bostwick J. Murray D.R. Staley C.A. et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol 10 2003 108-112
152. Simmons R.M. Brennan M. Christos P. King V. Osborne M. Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved? Ann Surg Oncol 9 2002 165-168
153. Chawla A.K. Kachnic L.A. Taghian A.G. Niemierko A. Zapton D.T. Powell S.N. Radiotherapy and breast reconstruction: complications and comesis with TRAM versus tissue expander/implant Int J Radiat Oncol Biol Phys 54 2002 520-526